Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FDA wants stronger warning labels for fen/phen

Aug. 29, 1997

First regulatory submission filed for Macritonin

Aug. 28, 1997

CURVES study results point in favor of atorvastatin

Aug. 28, 1997

FDA approves nonsurgical treatment for BPH

Aug. 28, 1997

Roche withdraws NDA for orlistat

Aug. 28, 1997

Ergo Science submits NDA for Ergoset

Aug. 27, 1997

Biologics license issued for Carticel

Aug. 27, 1997

Bone-targeted carbonic anhydrase inhibitors from RCT

Aug. 27, 1997

Natural products offer relief for BPH sufferers

Aug. 26, 1997

Ergo issued method-of-use patents for Ergoset

Aug. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...